XM does not provide services to residents of the United States of America.

India doctors end one-day strike over colleague's rape and murder



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>CORRECTED-India doctors end one-day strike over colleague's rape and murder</title></head><body>

Corrects headline to add dropped word 'day'

By Subrata Nag Choudhury and Jatindra Dash

KOLKATA, Aug 18 (Reuters) -Junior doctors in many Indian hospitals remained off the job on Sunday demanding swift justice for a colleague who was raped and murdered, despite the end of a 24-hour strike called by the country's biggest association of doctors.

Doctors across the country have held protests, candlelight marches and have refused to see non-emergency patients in the past week after the killing of the 31-year old postgraduate student of chest medicine around the early hours of Aug. 9 in the eastern city of Kolkata.

Women activists say the incident at the British-era R.G. Kar Medical College and Hospital has highlighted how women in India continue to suffer despite tougher laws following the gang-rape and murder of a 23-year-old student on a moving bus in Delhi in 2012.

"My daughter is gone but millions of sons and daughters are now with me," the father of the victim, who cannot be identified under Indian law, told reporters late on Saturday, referring to the protesting doctors. "This has given me a lot of strength and I feel we will gain something out of it."

India introduced sweeping changes to the criminal justice system, including tougher sentences, after the 2012 attack, but campaigners say little has changed and not enough has been done to deter violence against women.

The Indian Medical Association, whose strike ended at 6 a.m. (0030 GMT) on Sunday, told Prime Minister Narendra Modi that as 60% of India's doctors are women, he needed to intervene to ensure hospital staff were protected by security protocols akin to those at airports.

"All healthcare professionals deserve peaceful ambience, safety and security at workplace," it wrote in a letter to Modi.


'COULD STOP EMERGENCY SERVICES'

The government has urged doctors to return to duty to treat rising cases of dengue and malaria while it sets up a committee to suggest measures to improve protection for healthcare professionals.

Most doctors resumed their usual activities, IMA officials said, although Sunday is generally a holiday for non-emergency cases.

"The doctors are back to their routine," said Dr. Madan Mohan Paliwal, the IMA head in the most populous state, Uttar Pradesh. "The next course of action will be decided if the government does not take any strict steps to protect doctors... and this time we could stop emergency services too."

But the All India Residents and Junior Doctors’ Joint Action Forum said on Saturday it would continue a "nationwide cease-work" with a 72-hour deadline for authorities to conduct a thorough inquiry and make arrests.

Dr. Prabhas Ranjan Tripathy, additional medical superintendent of the All India Institute of Medical Sciences in the eastern city of Bhubaneswar, said junior doctors and interns had not resumed duty.

"The demonstrations are there today too," he told Reuters. "There is a lot of pressure on others because manpower is reduced."

R.G. Kar hospital has been rocked by agitation and rallies for more than a week. Police banned the assembly of five or more people to protest around the hospital for a week from Sunday and deployed police in riot gear.

Blocking meetings, demonstrations and processions was justified to prevent "breach of peace, disturbances of the public tranquillity", Kolkata Police Commissioner Vineet Goyal said in an order.

Reuters reporters saw no doctors in their usual protest site around the gates of the hospital on Sunday, as it rained in the area.



Reporting by Subrata Nag Choudhury and Jatindra Dash in Kolkata; Additonal reporting by Saurabh Sharma in Lucknow, Sunil Kataria in Kolkata and Tora Agarwala in Guwahati; Writing by Krishna N. Das; Editing by William Mallard

</body></html>

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.